Windsor Group LTD Bristol Myers Squibb CO Transaction History

Windsor Group LTD

$546 Million
Q3 2023

A detailed history of Windsor Group LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Windsor Group LTD holds 4,436 shares of BMY stock, worth $268,910. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,436

Previous 4,532 2.12%

Holding current value

$268,910

Previous $290,000 11.38%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $5,557 - $6,214	-96 Reduced 2.12%	4,436 $257,000
Q2 2023 Jul 12, 2023	SELL	$63.71 - $70.74 $8,855 - $9,832	-139 Reduced 2.98%	4,532 $290,000
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $1,780 - $2,108	-26 Reduced 0.55%	4,671 $341,000
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $2 - $1,767	23 Added 0.49%	4,697 $327,000
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $334,124 - $367,987	-4,601 Reduced 49.61%	4,674 $356,000
Q1 2022 May 04, 2022	SELL	$61.48 - $73.72 $10,759 - $12,901	-175 Reduced 1.85%	9,275 $721,000
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $27,673 - $32,260	-516 Reduced 5.18%	9,450 $587,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $1,775 - $2,079	30 Added 0.3%	9,966 $593,000
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $63,519 - $69,172	-1,026 Reduced 9.36%	9,936 $664,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $56,491 - $63,536	952 Added 9.51%	10,962 $692,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $5,312 - $6,019	-92 Reduced 0.91%	10,010 $621,000
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $40,717 - $45,120	-709 Reduced 6.56%	10,102 $603,000
Q2 2020 Jul 06, 2020	BUY	$54.82 - $64.09 $25,875 - $30,250	472 Added 4.57%	10,811 $636,000
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $17,910 - $26,027	-386 Reduced 3.6%	10,339 $576,000
Q4 2019 Jan 07, 2020	BUY	$49.21 - $64.19 $248,707 - $324,416	5,054 Added 89.12%	10,725 $688,000
Q3 2019 Oct 21, 2019	BUY	$42.77 - $50.71 $242,548 - $287,576	5,671 New	5,671 $287,000
Q2 2019 Jul 15, 2019	SELL	$44.62 - $49.34 $215,023 - $237,769	-4,819 Closed	0 $0
Q1 2019 Apr 09, 2019	SELL	$45.12 - $53.8 $32,576 - $38,843	-722 Reduced 13.03%	4,819 $230,000
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $120,437 - $156,178	-2,470 Reduced 30.83%	5,541 $288,000
Q3 2018 Oct 05, 2018	BUY	$55.19 - $62.25 $110,711 - $124,873	2,006 Added 33.41%	8,011 $497,000
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $112,176 - $139,815	-2,220 Reduced 26.99%	6,005 $332,000
Q1 2018 May 09, 2018	BUY	$59.92 - $68.98 $77,596 - $89,329	1,295 Added 18.69%	8,225 $520,000
Q4 2017 Mar 01, 2018	BUY	$59.94 - $65.35 $415,384 - $452,875	6,930	6,930 $425,000

Others Institutions Holding BMY

# of Institutions

2,573

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $129B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Group LTD with notifications on news.

Account

Windsor Group LTD Bristol Myers Squibb CO Transaction History